Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Common Equity: 2016-2024

  • Zepp Health's Common Equity fell 28.36% to $252.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $252.7 million, marking a year-over-year decrease of 28.36%. This contributed to the annual value of $252.7 million for FY2024, which is 28.36% down from last year.
  • Zepp Health's Common Equity amounted to $252.7 million in Q4 2024, which was down 28.36% from $352.8 million recorded in Q4 2023.
  • Zepp Health's 5-year Common Equity high stood at $460.3 million for Q4 2021, and its period low was $252.7 million during Q4 2024.
  • Its 3-year average for Common Equity is $331.6 million, with a median of $352.8 million in 2023.
  • As far as peak fluctuations go, Zepp Health's Common Equity climbed by 16.49% in 2020, and later fell by 28.36% in 2024.
  • Quarterly analysis of 5 years shows Zepp Health's Common Equity stood at $418.4 million in 2020, then grew by 10.01% to $460.3 million in 2021, then decreased by 15.43% to $389.3 million in 2022, then fell by 9.38% to $352.8 million in 2023, then fell by 28.36% to $252.7 million in 2024.
  • Its last three reported values are $252.7 million in Q4 2024, $352.8 million for Q4 2023, and $389.3 million during Q4 2022.